Study Design Sample Intervention Outcome Results Measures (Banu Bayar RCT n=20 Control Group : Visual Analog There was a ,Suat Erel 1. Passive Scale (VAS) and significant , Engin abduction of the Walking ability difference hallux with Scale (WAS) between pre and ,Erkan Sumer, traction of post-treatment Kılıçhan Bayar, the VAS scores 2011)5 evaluating joint resting and walking pain 2. Active in both groups, abduction of the showing a hallux decrease in both groups (P 3. Exercises < 0.05) performed 2 times a day with Also the 10 repetitions comparison of and for 8 weeks. the treatment results showed Study Group : better WAS 1. Passive results in the trial abduction of the group compared hallux with to traction of the control trial. the first (P < 0.05) joint 2. Active abduction of the hallux 3. Exercises performed 2 times a day with 10 repetitions and for 8 weeks. 4. Taping Eligibility criteria: Hallux valgus angle of at least 15° and maintaining regular attendance for the follow-ups. PEDro Score: 5/10 Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes
Study Design Sample Intervention Outcome Measures Results (Banu Bayar ,Suat Erel , Engin ,Erkan Sumer, Kılıçhan Bayar, 2011)5 RCT n=20 Control Group : 1. Passive abduction of the hallux with traction of the joint 2. Active abduction of the hallux 3. Exercises performed 2 times a day with 10 repetitions and for 8 weeks. Study Group : 1. Passive abduction of the hallux with traction of the first joint 2. Active abduction of the hallux 3. Exercises performed 2 times a day with 10 repetitions and for 8 weeks. 4. Taping Visual Analog Scale (VAS) and Walking ability Scale (WAS) There was a significant difference between pre and post-treatment VAS scores evaluating resting and walking pain in both groups, showing a decrease in both groups (P < 0.05) Also the comparison of the results showed better WAS results in the group compared to the control (P < 0.05) Eligibility criteria: Hallux valgus angle of at least 15° and maintaining regular attendance for the follow-ups. PEDro Score: 5/10 Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes trial treatment trial.